TFR Capital LLC. Takes Position in Danaher Co. (NYSE:DHR)

TFR Capital LLC. purchased a new stake in Danaher Co. (NYSE:DHR - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 5,349 shares of the conglomerate's stock, valued at approximately $1,228,000.

Other large investors have also recently modified their holdings of the company. LaFleur & Godfrey LLC grew its stake in Danaher by 1.5% in the 4th quarter. LaFleur & Godfrey LLC now owns 29,855 shares of the conglomerate's stock worth $6,853,000 after buying an additional 440 shares in the last quarter. Blue Trust Inc. grew its position in Danaher by 75.7% in the fourth quarter. Blue Trust Inc. now owns 16,615 shares of the conglomerate's stock worth $3,814,000 after acquiring an additional 7,157 shares in the last quarter. Capital Asset Advisory Services LLC grew its position in Danaher by 4.2% in the fourth quarter. Capital Asset Advisory Services LLC now owns 10,973 shares of the conglomerate's stock worth $2,577,000 after acquiring an additional 440 shares in the last quarter. Union Bancaire Privee UBP SA bought a new position in Danaher in the fourth quarter valued at $74,551,000. Finally, Cornerstone Wealth Group LLC raised its position in Danaher by 9.1% during the fourth quarter. Cornerstone Wealth Group LLC now owns 1,179 shares of the conglomerate's stock valued at $271,000 after purchasing an additional 98 shares in the last quarter. Institutional investors own 79.05% of the company's stock.

Danaher Trading Down 0.5%

DHR traded down $0.93 during midday trading on Friday, reaching $189.54. 6,514,078 shares of the company's stock traded hands, compared to its average volume of 3,485,040. Danaher Co. has a 52 week low of $171.00 and a 52 week high of $281.70. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The firm has a fifty day moving average of $193.18 and a two-hundred day moving average of $214.13. The stock has a market capitalization of $135.65 billion, a price-to-earnings ratio of 35.90, a P/E/G ratio of 2.66 and a beta of 0.80.

Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.26. Danaher had a return on equity of 10.82% and a net margin of 16.33%. The firm had revenue of $5.74 billion for the quarter, compared to analysts' expectations of $5.58 billion. On average, equities analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.68%. Danaher's payout ratio is 24.85%.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the company. Raymond James reiterated a "market perform" rating on shares of Danaher in a report on Monday, February 3rd. Royal Bank of Canada restated an "outperform" rating and issued a $250.00 target price on shares of Danaher in a research report on Wednesday, April 23rd. Citigroup reiterated a "buy" rating on shares of Danaher in a research report on Monday, April 7th. UBS Group decreased their price target on shares of Danaher from $275.00 to $240.00 and set a "buy" rating on the stock in a research note on Wednesday, April 23rd. Finally, Stifel Nicolaus raised shares of Danaher from a "hold" rating to a "buy" rating and set a $260.00 target price on the stock in a report on Friday, March 14th. Five analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $263.24.

Insider Activity

In other Danaher news, Chairman Steven M. Rales sold 1,250,000 shares of the firm's stock in a transaction on Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the transaction, the chairman now owns 3,105,808 shares of the company's stock, valued at approximately $611,036,665.92. This trade represents a 28.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Christopher Paul Riley sold 15,805 shares of the business's stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the sale, the executive vice president now owns 15,179 shares in the company, valued at approximately $3,005,442. This trade represents a 51.01% decrease in their position. The disclosure for this sale can be found here. Insiders own 11.20% of the company's stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.